Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBOAT4 | Q96T53 | 10/20 | 0.59 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.37 |
| ▸ | NCF1 | P14598 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19979147 | 0.83 | MBOAT4 (0.46) | MBOAT4HRH3HRH4NCF1ACHE | |
| SCHEMBL16699213 | 0.83 | MBOAT4 (0.69) | MBOAT4 | |
| SCHEMBL16699454 | 0.82 | MBOAT4 (0.52) | MBOAT4HRH3HTR4 | |
| SCHEMBL18166114 | 0.81 | MBOAT4 (0.66) | MBOAT4 | |
| Hydrochloric Acid SCHEMBL16699451 | 0.81 | MBOAT4 (0.51) | MBOAT4HRH3HTR4 | |
| SCHEMBL16728368 | 0.80 | MBOAT4 (0.77) | MBOAT4 | |
| SCHEMBL16698876 | 0.80 | MBOAT4 (0.76) | MBOAT4 | |
| SCHEMBL19971821 | 0.80 | MBOAT4 (0.64) | MBOAT4 | |
| SCHEMBL19311928 | 0.80 | MBOAT4 (0.76) | MBOAT4 | |
| SCHEMBL19971822 | 0.80 | MBOAT4 (0.64) | MBOAT4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079729-A1 | GHRELIN 0-ACYL TRANSFERASE INHIBITORS | ELI LILLY AND COMPANY | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079729-A1 | GHRELIN 0-ACYL TRANSFERASE INHIBITORS | MBOAT4, GIPR, PLAAT2 | MBOAT4 1/4885HRH3 4291/4885HRH4 3601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.